All Pharma News
Allogene Starts Phase 2 Trial For CAR T Product In Large B-Cell Lymphoma

Allogene Starts Phase 2 Trial For CAR T Product In Large B-Cell Lymphoma
GLOBENEWSWIRE
20 Jun 2024
Share Share
Allogene Oncology Summit Featured: Cowen Participation Scheduled 2024

Allogene Oncology Summit Featured: Cowen Participation Scheduled 2024
GLOBENEWSWIRE
23 May 2024
Share Share
Allogene`s $110M offering

Allogene`s $110M offering
PRESS RELEASE
13 May 2024
Share Share
Allogene Therapeutics Q1 2024 Financials, Business Update

Allogene Therapeutics Q1 2024 Financials, Business Update
GLOBENEWSWIRE
13 May 2024
Share Share
Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock

Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
GLOBENEWSWIRE
13 May 2024
Share Share
Allogene To Report Q1 Results, Provide Business Update

Allogene To Report Q1 Results, Provide Business Update
GLOBENEWSWIRE
06 May 2024
Share Share
Allogene Awarded CIRM Grant for Allogeneic CAR-T in Renal Cell Cancer

Allogene Awarded CIRM Grant for Allogeneic CAR-T in Renal Cell Cancer
GLOBENEWSWIRE
26 Apr 2024
Share Share
Allogene Therapeutics Announces Q2 Investor Conference Participation

Allogene Therapeutics Announces Q2 Investor Conference Participation
GLOBENEWSWIRE
09 Apr 2024
Share Share
Allogene Reports Fourth Quarter and Full Year 2023 Financial Results

Allogene Reports Fourth Quarter and Full Year 2023 Financial Results
GLOBENEWSWIRE
14 Mar 2024
Share Share
Allogene Therapeutics and Arbor Biotechnologies Announce Agreement

Allogene Therapeutics and Arbor Biotechnologies Announce Agreement
GLOBENEWSWIRE
12 Mar 2024
Share Share